Document is current

Article History

Received: 31 January 2025

Accepted: 16 December 2025

First Online: 30 January 2026

Declarations

:

: This project was non-clinical and non-interventional and was for patient insight purposes only. Institutional Review Board (IRB) and Research Ethics Committee (REC) approvals were not required nor sought because the research did not meet the requirements for needing ethical approval, per section 1.3 of the EphMRA guidelines and as per Health Research Authority (HRA) decision tool.

: All the authors confirm that consent for publication has been obtained and that all patient/personal identifiers have been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of the story.

: A poster regarding this publication was submitted, accepted and presented at SIAIIC 2023 (HOTEL SAVOIA REGENCY – Via del Pilastro 2–40127 Bologna; 27.10.2023).

: Authors LB, MRM, CS, and LC are employed by GSK and hold financial equities in GSK. Author GC has received consulting fees, payments or honoraria for lectures, presentations, speaker bureaus, advisory boards, support for attending meetings and/or travel from AZ, GSK, Sanofi and Chiesi Pharmaceutical Companies. Author IB has received payments or honoraria for lectures, presentations, speaker bureaus, or educational events from AZ, Sanofi and Chiesi Pharmaceutical Companies. Author FA has received consulting fees, payments or honoraria for lectures, presentations, speaker bureaus, advisory boards, support for attending meetings and/or travel from Sanofi, GSK, Firma and Novartis Pharmaceutical Companies. Author DG has received payment or honoraria for lectures, presentations, speaker bureaus, educational events, and support for attending meetings and/or travel. The remaining authors declare that they have no conflicts of interest.